$SDGR
Schrodinger, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$30.60
▲+0.96%+$0.290
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateSchrodinger, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is SDGR up today? It is at $30.60 (+0.96%), and our scanner flagged it 252 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment SDGR spikes, and full due diligence on SDGR — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $SDGR 252 times in the last 30 days. Create a free account to track $SDGR, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
SDGR is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 3 unusual-volume and momentum alerts on SDGR today, peaking at 71.0x its normal volume. A recent catalyst in the news: “Global Drug Discovery AI Tools Market - Strategic Forecast 2026-2032 | Generative AI, Cloud Platforms, and Integrated R&D Workflows Create New Growth Opportunities.” Early read: bullish.
Likely catalystSchrodinger, Inc.: Q2 FY2026 results, three months to Jun 30, 2026, from an SEC filing. Read it →Latest filing4Insider trade (Form 4)Sep 21, 2026 · 13 days agoSources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Akinsanya Karen Officer | Sold (automatic/other) | -32K 0.05% of company | sold 31% | 70K | $885K at $28.00 | Sep 17, 26 |
Akinsanya Karen Officer | Other | 32K 0.05% of company | added 45% | 102K | $137K at $4.34 | Sep 17, 26 |
Jain Rachit Officer | Sold (automatic/other) | -875 | sold 1.7% | 51K | $14K at $15.60 | Jul 16, 26 |
Friesner Richard Director | Sold (automatic/other) | -679K 1.1% of company | n/a | n/a | n/a | Jun 26, 26 |
Friesner Richard Director | Acquired (grant/award) | +679K 1.1% of company | added 100% | 708K | n/a | Jun 26, 26 |
Van Kralingen Bridget A Director | Acquired (grant/award) | +8K 0.01% of company | added 71% | 20K | n/a | Jun 22, 26 |
Thornberry Nancy Director | Acquired (grant/award) | +8K 0.01% of company | added 47% | 25K | n/a | Jun 22, 26 |
Sender Gary Director | Acquired (grant/award) | +8K 0.01% of company | added 47% | 25K | n/a | Jun 22, 26 |
Lynton Michael Director | Acquired (grant/award) | +8K 0.01% of company | added 47% | 25K | n/a | Jun 22, 26 |
Kapeller-Libermann Rosana Director | Acquired (grant/award) | +8K 0.01% of company | added 47% | 25K | n/a | Jun 22, 26 |
Ginsberg Gary L Director | Acquired (grant/award) | +8K 0.01% of company | added 47% | 25K | n/a | Jun 22, 26 |
Friesner Richard Director | Acquired (grant/award) | +8K 0.01% of company | added 1.2% | 690K | n/a | Jun 22, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
SDGR is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 3 unusual-volume and momentum alerts on SDGR today, peaking at 71.0x its normal volume. A recent catalyst in the news: “Global Drug Discovery AI Tools Market - Strategic Forecast 2026-2032 | Generative AI, Cloud Platforms, and Integrated R&D Workflows Create New Growth Opportunities.” Early read: bullish.
SDGR last traded at $30.60, up 0.96% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Schrodinger, Inc. Common Stock (SDGR) is next expected to report earnings on Wednesday, November 4, 2026, about 30 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The SDGR Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged SDGR 252 times in the last 30 days.
SDGR (Schrodinger, Inc. Common Stock) trades on XNAS, with a market cap of about $1.91B in the PHARMACEUTICAL PREPARATIONS sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge SDGR for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$SDGR discussion
Sign in to ask a question or join the discussion.